User menu

Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.

Bibliographic reference Donadieu, J. ; Auclerc, M F ; Baruchel, A ; Leblanc, T ; Landman-Parker, J ; et. al. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group.. In: British journal of haematology, Vol. 102, no. 3, p. 729-39 (1998)
Permanent URL
  1. Aricò Maurizio, Basso Giuseppe, Zanesco Luigi, Mandelli Franco, Rizzari Carmelo, Masera Giuseppe, Colella Roberto, Barisone Elena, Rondelli Roberto, Pession Andrea, Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia, 10.1002/1097-0142(19950401)75:7<1684::aid-cncr2820750720>;2-2
  2. Bahner-Ennassih, Annals of Hematology, 70, 131 (1995)
  3. Campana, Blood, 85, 1416 (1995)
  4. Chessells J.M., Bailey C.C., Richards S.M., Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X, 10.1016/s0140-6736(95)90164-7
  5. Collet , D. 1994 Modelling Survival Data in Medical Research
  6. Cortes Jorge E., Kantarjian Hagop M., Acute lymphoblastic leukemia a comprehensive review with emphasis on biology and therapy, 10.1002/1097-0142(19951215)76:12<2393::aid-cncr2820761203>;2-p
  7. Crist W., Boyett J., Pullen J., van Eys J., Vietti T., Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: A pediatric oncology group review, 10.1002/mpo.2950140306
  8. Crist, Blood, 76, 117 (1990)
  9. Crist, Blood, 76, 489 (1990)
  10. Eden O. B., Lilleyman J. S., Richards S., Shaw M. P., Peto J., Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood), 10.1111/j.1365-2141.1991.tb04415.x
  11. Fletcher, Blood, 77, 435 (1991)
  12. Gajjar, Blood, 86, 1292 (1995)
  13. Gibbons B., Katz F. E., Ganly P., Chessells J. M., Infant acute lymphoblastic leukaemia with t(11;19), 10.1111/j.1365-2141.1990.tb02581.x
  14. Hammond Denman, Sather Harland, Nesbit Mark, Miller Dennis, Coccia Peter, Bleyer Archie, Lukens John, Siegel Stuart, Analysis of prognostic factors in acute lymphoblastic leukemia, 10.1002/mpo.2950140305
  15. Harbott J., Ritterbach J., Janka-Schaub G., Ludwig W.-D., Reiter A., Riehm H., Lampert F., Cytogenetics of Childhood Acute Lymphoblastic Leukemia in Multicenter Trials, Acute Leukemias II (1990) ISBN:9783540509844 p.451-458, 10.1007/978-3-642-74643-7_82
  16. Hecker, Anticancer Research, 14, 2559 (1994)
  17. Hiddeman, Proceedings of the American Society for Clinical Oncology, 12, 318 (1993)
  18. Jacquillat C., Weil M., Auclerc M.F., Chastang C., Flandrin G., Izrael V., Schaison G., Degos L., Boiron M., Bernard J., Prognosis and treatment of acute lymphoblastic leukemia : Study of 650 patients, 10.1007/bf00254045
  19. Kaspers, Annals of Hematology, 70, 129 (1995)
  20. Lennard L, Lilleyman J S, Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia., 10.1200/jco.1989.7.12.1816
  21. Lilleyman J. S., Hann I. M., Stevens R. F., Richards S. M., Eden O. B., Chessells J. M., Bailey C. C., Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients, 10.1111/j.1365-2141.1992.tb08170.x
  22. Look, Blood, 65, 1079 (1985)
  23. McLean, Blood, 88, 4252 (1996)
  24. Mastrangelo R., Poplack D., Bleyer A., Riccardi R., Sather H., D'Angio G., Report and recommendations of the rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment, 10.1002/mpo.2950140317
  25. Miller D R, Coccia P F, Bleyer W A, Lukens J N, Siegel S E, Sather H N, Hammond G D, Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group., 10.1200/jco.1989.7.12.1807
  26. Miller Denis R., Leikin Sandford, Albo Vincent, Sather Harland, Karon Myron, Hammond Denman, Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141: A report from childrens cancer study group, 10.1002/1097-0142(19830315)51:6<1041::aid-cncr2820510612>;2-g
  27. NAGELKERKE N. J. D., A note on a general definition of the coefficient of determination, 10.1093/biomet/78.3.691
  28. Neglia Joseph P., Day Deborah L., Swanson Timothy V., Ramsay Norma K.C., Robison Leslie L., Nesbit Mark E., Kidney Size at Diagnosis of Childhood Acute Lymphocytic Leukemia : Lack of Prognostic Significance for Outcome, 10.1097/00043426-198824000-00005
  29. Pieters Rob, Kaspers Gertjan J. L., Klumper Edwin, Veerman Anjo J.P., Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: The state of the art, 10.1002/mpo.2950220502
  30. Pieters, Leukemia, 6, 375 (1992)
  31. Pinkel D, Selecting treatment for children with acute lymphoblastic leukemia., 10.1200/jco.1996.14.1.4
  32. Privitera, Blood, 79, 1781 (1992)
  33. Pui, Blood, 70, 247 (1987)
  34. Pui, Blood, 77, 440 (1991)
  35. Pui, Blood, 73, 1963 (1989)
  36. Pui C H, Williams D L, Roberson P K, Raimondi S C, Behm F G, Lewis S H, Rivera G K, Kalwinsky D K, Abromowitch M, Crist W M, Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia., 10.1200/jco.1988.6.1.56
  37. Raimondi, Blood, 79, 3245 (1992)
  38. Rautonen, Blood, 71, 989 (1988)
  39. Reiter, Blood, 84, 3122 (1994)
  40. Ribeiro, Hematological Pathology, 7, 121 (1993)
  41. Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children, 10.1016/s0140-6736(96)91615-3
  42. Riehm H., Reiter A., Schrappe M., Berthold F., Dopfer R., Gerein V., Ludwig R., Ritter J., Stollmann B., Henze G., Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83), 10.1055/s-2008-1026781
  43. Rivera Gaston K., Pinkel Donald, Simone Joseph V., Hancock Michael L., Crist William M., Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital, 10.1056/nejm199310283291801
  44. Robison, American Journal of Pediatric Hematology and Oncology, 1, 3 (1980)
  45. Russo, Blood, 77, 1050 (1991)
  46. Santana, Leukemia, 4, 87 (1990)
  47. Schaison, Leukemia, 6, 148 (1992)
  48. Schemper Michael, Smith Terry L., A note on quantifying follow-up in studies of failure time, 10.1016/0197-2456(96)00075-x
  49. SCHEMPER MICHAEL, STARE JANEZ, EXPLAINED VARIATION IN SURVIVAL ANALYSIS, 10.1002/(sici)1097-0258(19961015)15:19<1999::aid-sim353>;2-d
  50. Schorin M A, Blattner S, Gelber R D, Tarbell N J, Donnelly M, Dalton V, Cohen H J, Sallan S E, Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01., 10.1200/jco.1994.12.4.740
  51. Secker-Walker Lorna M., Chessells Judith M., Stewart Elizabeth L., Swansbury G. J., Richards Susan, Lawler Sylvia D., Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up, 10.1111/j.1365-2141.1989.tb07713.x
  52. Smith M, Arthur D, Camitta B, Carroll A J, Crist W, Gaynon P, Gelber R, Heerema N, Korn E L, Link M, Murphy S, Pui C H, Pullen J, Reamon G, Sallan S E, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R, Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia., 10.1200/jco.1996.14.1.18
  53. Steinherz P G, Gaynon P S, Breneman J C, Cherlow J M, Grossman N J, Kersey J H, Johnstone H S, Sather H N, Trigg M E, Chappell R, Hammond D, Bleyer W A, Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group., 10.1200/jco.1996.14.2.389
  54. Steinherz Peter G., Siegel Stuart E., Bleyer W. Archie, Kersey John, Chard Ronald, Coccia Peter, Leikin Sanford, Lukens John, Neerhout Robert, Nesbit Mark, Miller Denis R., Reaman Gregory, Sather Harland, Hammond Denman, Lymphomatous presentation of childhood acute lymphoblastic leukemia. A subgroup at high risk of early treatment failure, 10.1002/1097-0142(19910815)68:4<751::aid-cncr2820680416>;2-t
  55. Uckun, Blood, 90, 28 (1997)
  56. Uckun, Blood, 85, 873 (1995)
  57. Uckun, Blood, 88, 4288 (1996)
  58. Wiersma Susan R., Ortega Jorge, Sobel Eugene, Weinberg Kenneth I., Clinical Importance of Myeloid-Antigen Expression in Acute Lymphoblastic Leukemia of Childhood, 10.1056/nejm199103213241204